A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin (Q33398776)

26 July 2017

A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin (English)

1 reference

26 July 2017

1 reference

1 reference

Nimish Patel

1

0 references

author name string

Hillary VanDeWall

2

1 reference

26 July 2017

Linda Tristani

3

1 reference

26 July 2017

Antonio Rivera

4

1 reference

26 July 2017

Benjamin Woo

5

1 reference

26 July 2017

Amanda Dihmess

6

1 reference

26 July 2017

Hsin K Li

7

1 reference

26 July 2017

Raymond Smith

8

1 reference

26 July 2017

Thomas P Lodise

9

1 reference

26 July 2017

language of work or name

English

0 references

publication date

15 December 2011

1 reference

Journal of Antimicrobial Chemotherapy

26 July 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 July 2017

67

1 reference

26 July 2017

3

1 reference

26 July 2017

727-735

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

26 July 2017

1 reference

Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Quinine/quinidine-induced thrombocytopenia: a great imitator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Vancomycin-induced immune thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Regression Analysis of Grouped Survival Data with Application to Breast Cancer Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Acute vancomycin-dependent immune thrombocytopenia as an anamnestic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

Thrombocytopenia induced by vancomycin-dependent platelet antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR522

21 January 2018

Identifiers

DOI

10.1093/JAC/DKR522

1 reference

26 July 2017

1 reference